Sage Journals: Discover world-class research

Free access

Review article

First published 2018-9

Practical aspects of extended half-life products for the treatment of haemophilia

Thierry Lambert, Gary Benson, Gerry Dolan [...]

Therapeutic Advances in Hematology

Open access

Research article

First published 2023-3

‘People just dae wit they can tae get by’: Exploring the half-life of deindustrialisation in a Scottish community

Andy Clark

The Sociological Review

Retricted access

Research article

First published 1968-5

3. Half-Life and Volume of Distribution

John G. Wagner

Annals of Pharmacotherapy

Retricted access

Research article

First published 2016-10

Estimation of half-life periods in nonlinear data with fractional polynomials

Benjamin Mayer, Frieder Keller, Tatiana Syrovets [...]

Statistical Methods in Medical Research

Retricted access

Research article

First published 2022-11

Emotion regulation through music and mindfulness are associated with positive solitude differently at the second half of life

Noa Bachman, Yuval Palgi, Ehud Bodner

International Journal of Behavioral Development

Retricted access

Letter

First published 2024-6

Half-life of Apixaban During Massive Apixaban Overdose

Ju-Tae Sohn

Journal of Pharmacy Practice

Free access

Research article

First published 2025

Estimation of half-life with confidence interval for phosphatidylethanol (PEth) in blood based on two consecutive measurements

Johan Bjerner, Michael Sovershaev, Elisabeth Wiik Vigerust [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Free access

Review article

First published 2018-6

Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia

Massimo Morfini, Stefano Gherardini

Therapeutic Advances in Hematology

Retricted access

Research article

First published 1994-1

Serum Tumor Marker Half-Life during Chemotherapy in Patients with Germ Cell Tumors

G.J. Bosl, M.D. Head

The International Journal of Biological Markers

Open access

Review article

First published 2018-11

Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B

Johnny N. Mahlangu

Therapeutic Advances in Hematology

Search results